Urogen's Chief Medical Officer Insider Trade: 400K Sale Insights
A high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
Choose the right SP 500 fund for retirement in 2024 by evaluating fees, track record, and diversification.
24,199 articlesA high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
Today’s jump in the super micro computer stock surprised many, even as revenue guidance cooled. This article breaks d...
As winter approaches, Vail Resorts relies on Epic Pass momentum to power revenue and cash flow. This investor-focused...
A February pullback gave investors a clearer path to big AI winners. Here are three mega-cap picks, plus concrete ste...
e.l.f. beauty shares down have caught the attention of investors as momentum slows and margins feel pressure. This ar...
Starting with $1,000, you can build a durable energy stock portfolio. This guide shows the smartest energy stocks wit...
Palantir sits at the intersection of data software, government work, and commercial growth. Is it a palantir: risky i...
Elastic faces a pivotal quarter as it closes 2026 with a cloud-first strategy. This article breaks down what to watch...
ASML Holding stock popped today as investors weighed AI-driven demand, backlog strength, and a brighter outlook for c...
Oil remains below $70, but the bigger story is the Federal Reserve's June inflation forecast. This guide explains wha...
Uniswap activated its fee switch today, enabling on-chain UNI buybacks funded by protocol fees. The move links revenu...
Bitcoin selling pressure weakens as a surge in U.S. spot ETF inflows shows renewed demand. This article breaks down w...